Astellas Pharma Inc
A Global Company
Astellas Pharma Inc is one of the top 20 pharmaceutical companies in the world, employing 55 people in Greece. As a young and forward-thinking company, Astellas Pharma is dedicated to improving the lives and health of people around the world through the introduction of innovative and reliable pharmaceutical products.
Now, since the merger of Yamanouchi and Fujisava in 2005, Astellas Pharma continues to remain committed to developing first-in-class and best-in-class products in key therapeutic areas by combining outstanding R&D with marketing capabilities and continuing growth in the global pharmaceuticals market.
In October 2006, Astellas Pharma Inc. launched its management vision, Vision 2015, with the aim of becoming a global category leader ( GCL) in several therapeutic categories in which high unmet medical needs exist and an exceptional degree of expertise is required. Integral to this vision is “Changing Tomorrow”, a wide –reaching campaign , which aims to express the company’s potential for creating a better tomorrow for all its stakeholders and basically the patients. At Astellas, each employee is consistently encouraged to work in a spirit of leadership, innovation, and commitment, while externally Astellas’ communications to the wider world express the company’s ambitions, advantages and values as we set about Changing Tomorrow.
In Astellas Greece we focus on six important therapeutic areas:
Transplantation : Prograf, Advagraf
Urology : Omnic Tocas, Vesicare
Anti -Infectives : Mycamine
Dermatology : Protopic
Hypertension : Vasexten
Pain : Qutenza
The philosophy of Astellas Pharma Inc. highlights our attitude towards all our stakeholders-healthcare professionals, shareholders, employees, and the global community. It embodies our vision of unceasingly contributing to the health of people around the world by providing innovative and reliable pharmaceutical products, and thereby constantly enhancing the enterprise value of Astellas Pharma Inc.